Geoff Barnes and Jacob Kurlander will be speaking about a survey of providers involved in colonoscopy care for patients on oral anticoagulation. Specifically, they want to assess who various providers feel is responsible for coordinating anticoagulation care around the time of a colonoscopy. They hypothesize that everyone will treat this like a “hot potato” and try to assign responsibility to other providers.
Page not found
Ray De Vries and Tom Tomlinson will be speaking about a deliberative democracy session on non-welfare interests in biobanking. They will be looking for feedback on materials including the presentations to be given by experts.
Imagine that you have just been diagnosed with high cholesterol. You are asked to decide whether or not take a type of drug called a statin to lower your cholesterol. In order to help you decide, you are given information about the risk and benefits of taking statins.
On the following page, consider 4 different formats for presenting the risks and benefits.
When Death Comes Callin': Songs and Reflections About Death
Charlotte DeVries, Jeanne Mackey, Merilynne Rush, and friends offer a program of songs and brief readings reflecting various perspectives on death - humorous, sad, thoughtful, and quirky.
Lunch is provided on a first-come, first-served basis.
Check out the Ethics Path available to Michigan medical students through the Paths of Excellence (PoE) program. The ethics path provides opportunities for individualized, independent study, combined with field work with CBSSM, and a capstone project in the M4 year.
Click here for more information about the PoE program.
Vaccine refusal has an impact on public health; however, research has shown that it is very difficult to change attitudes towards vaccines. People are often hesitant about vaccines because they don’t trust that potential harms are documented and reported. The question is: how can we increase trust and vaccine utilization?
Seeking feedback regarding developing a survey to assess the physicians' understanding of risks associated with proton pump inhibitors.Specifically, we are seeking input on the design of patient vignettes that include some randomized elements, and in the design of questions about providers quantitative estimates of PPI risk.